|
Sign In to gain access to subscriptions and/or personal tools.
|
Normal endothelial cell function
J D Pearson
Centre for Cardiovascular Biology & Medicine, King's College London, Guy's Campus, London SE1 1UL, UK
Endothelial cell functions, primarily involving regulated mediator secretion or altered surface protein expression, are vital for normal homeostasis. Endothelial cells secrete the potent vasodilator and anti-platelet agent prostacyclin and nitric oxide, and also the potent vasoconstrictor peptide endothelin-1; they control the selective adhesion and emigration of leukocytes from the bloodstream; and they are the source of circulating von Willebrand factor, tissue plasminogen activator and type 1 plasminogen activator inhibitor. The properties of healthy endothelium ensure that an antithrombotic and anticoagulant balance is maintained in the bloodstream, and provide a tonic vasodilator action that controls blood flow and pressure on a minute-to-minute basis. Disturbances of normal endothelial function are strongly implicated in the pathogenesis of atherosclerosis and autoimmune vasculitic diseases including lupus.
Key Words: endothelium nitric oxide prostacyclin thrombin leukocyte platelet coagulation fibrinolysis
Lupus, Vol. 9, No. 3,
183-188 (2000)
DOI: 10.1191/096120300678828299

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J Pope
An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?
Lupus,
April 1, 2008;
17(4):
274 - 277.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Touyz
Regulation of Endothelial Nitric Oxide Synthase by Thrombin
Hypertension,
March 1, 2007;
49(3):
429 - 431.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lopez-Rivera, T. R. Lizarbe, M. Martinez-Moreno, J. M. Lopez-Novoa, A. Rodriguez-Barbero, J. Rodrigo, A. P. Fernandez, A. Alvarez-Barrientos, S. Lamas, and C. Zaragoza
Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration
PNAS,
March 8, 2005;
102(10):
3685 - 3690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Ray, D. A. Morrow, C. M. Gibson, S. Murphy, E. M. Antman, E. Braunwald, and for the ENTIRE-TIMI 23 Study Group
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy
Eur. Heart J.,
March 1, 2005;
26(5):
440 - 446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-Y. Chong, A.D. Blann, and G.Y.H. Lip
Assessment of endothelial damage and dysfunction: observations in relation to heart failure
QJM,
April 1, 2003;
96(4):
253 - 267.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wojta, C. Kaun, G. Zorn, M. Ghannadan, A. W. Hauswirth, W. R. Sperr, G. Fritsch, D. Printz, B. R. Binder, G. Schatzl, et al.
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils
Blood,
June 28, 2002;
100(2):
517 - 523.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|